74 results on '"Chopin, Dominique K."'
Search Results
2. Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma
3. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status
4. MOLECULAR GRADING WITH FGFR3 AND MIB-1 IS HIGHLY PREDICTIVE AND REPRODUCIBLE IN NON-MUSCLE INVASIVE BLADDER CANCER
5. THE EXPRESSION OF TWIST HAS AN IMPACT ON SURVIVAL IN HUMAN BLADDER CANCER AND IS CORRELATED TO THE SMOKING STATUS
6. Erratum: Corrigendum: Regional copy number–independent deregulation of transcription in cancer
7. Regional copy number–independent deregulation of transcription in cancer
8. Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation
9. 723: Significance of Tumor Size in Locally Advanced Renal Cell Carcinoma (PT3A): An International Multicenter Experience
10. 739: The Effect of Competing Mortality on the Risk of Cancer-Specific Survival in Kidney Cancer
11. 835: Prophylactic Ofloxacin to Improve Tolerance of BCG Intravesical Instillations: A Randomised Prospective, Double Blind, Placebo-Controlled, Multicentre Study in Patients with Mid to High Risk Superficial Bladder Tumors
12. 740: Can PT2 Classification for Renal Cell Carcinoma be Improved? an International Multicenter Experience?
13. Sensitive Allele-Specific PCR Assay Able to Detect FGFR3 Mutations in Tumors and Urine from Patients with Urothelial Cell Carcinoma of the Bladder
14. A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer Cells
15. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
16. 917: FGFR3 Mutations as Classifier of Tumor Progression and specific survival in T1G3 Urothelial Cell Carcinoma of the Bladder
17. 582: P-AKT Pathway Activation and Inhibition Depends on N-Cadherin or P-EGFR Expression in Invasive Human Bladder Cancer Cell Lines
18. 1438: Pharmacogenomic Analysis of Benign Prostatic Hyperplasia
19. 691: Experience with 650 Laparoscopic Radical Prostatectomy
20. 970: Multi-Institutional European Internal Validation of a Competing Risks Survival Nomogram for Patients Treated for Renal Cell Carcinoma
21. 996: Prognostic Significance of T3A Renal Cell Carcinoma with Adrenal Gland Involvement: An International Multicenter Experience
22. 473: The Effects of Long Term Finasteride Treatment on Prostate Cancer Morphology
23. SYMPTOMS AS WELL AS TUMOR SIZE PROVIDE PROGNOSTIC INFORMATION ON PATIENTS WITH LOCALIZED RENAL TUMORS
24. MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA
25. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study
26. SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
27. Growth, Differentiation and Senescence of Normal Human Urothelium in an Organ-Like Culture
28. Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)
29. Nitrosulindac (NCX 1102): A new nitric oxide‐donating non‐steroidal anti‐inflammatory drug (NO‐NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines
30. Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
31. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications
32. Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy
33. FGFR3 and TP53 gene mutations define distinct pathways at initial diagnosis in urothelial cell carcinomas of the bladder
34. Epidermal Growth Factor Receptor Regulates Normal Urothelial Regeneration
35. Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome
36. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells
37. PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER
38. PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER
39. T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCER
40. T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCER
41. The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse
42. Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer
43. Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer
44. Relationship between penile thermal sensory threshold measurement and electrophysiologic tests to assess neurogenic impotence
45. HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER
46. ASSESSMENT OF PENILE SMALL NERVE FIBER DAMAGE AFTER TRANSURETHRAL RESECTION OF THE PROSTATE BY MEASUREMENT OF PENILE THERMAL SENSATION
47. ASSESSMENT OF PENILE SMALL NERVE FIBER DAMAGE AFTER TRANSURETHRAL RESECTION OF THE PROSTATE BY MEASUREMENT OF PENILE THERMAL SENSATION
48. HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER
49. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients
50. Biomarkers of renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.